// App-Quantinova.ai

P1086 : FAVEZELIMAB (ANTI–LAG-3) AND PEMBROLIZUMAB CO-BLOCKADE IN ANTI–PD-1–NAIVE PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA: AN OPEN-LABEL PHASE 1/2 STUDY

Researchers

Presenter

  • Gareth Gregory

Principal Investigators

  • John Timmerman

  • David Lavie

  • Peter Borchmann

  • Alex F. Herrera

  • Leonard Minuk

  • Vladan Vucinic

  • Philippe Armand

  • Abraham Avigdor

  • Robin Gasiorowski

  • Yair Herishanu

  • Colm Keane

  • John Kuruvilla

  • John Palcza

  • Patricia Marinello

  • Nathalie A. Johnson

Medical Centers

  • UCLA Medical Center,Los Angeles,Verenigde Staten

  • Concord Hospital, University of Sydney, Concord, Australia

  • Princess Alexandra Hospital, Brisbane, Australia

  • Co., Inc.,Kenilworth,United States

  • Dana-Farber Cancer Institute Boston,Boston,Stati Uniti

  • Dana-Farber Cancer Institute, Boston, MA, United States

  • Concord Hospital, University of Sydney, Concord, Australia

  • Princess Alexandra Hospital,Brisbane,Австралия

  • Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel

  • Cancer Care Manitoba, Winnipeg, MB, Canada

  • Princess Alexandra Hospital, Brisbane, Australia

  • UCLA Medical Center,Los Angeles,États-unis

  • Dana-Farber Cancer Institute, Boston, MA

  • Concord Hospital, University of Sydney, Concord, Australia

  • School of Clinical Sciences, Monash University, Melbourne, Australia

  • Princess Alexandra Hospital, Brisbane, Australia

  • Hadassah Medical Center, Jerusalem, Israel

  • City of Hope, Duarte, United States

  • UCLA Medical Center,Los Angeles,États-unis

  • University of Leipzig Medical Center,Leipzig,Germania

  • University of Leipzig Medical Center,Leipzig,Germania

  • Princess Margaret Cancer Centre,...

  • Cancer Care Manitoba, Winnipeg, MB, Canada

  • Co., Inc.,Kenilworth,Estados Unidos

  • UCLA Medical Center, CA

  • Princess Alexandra Hospital, Brisbane, Australia

  • UCLA Medical Center,Los Angeles,Verenigde Staten

  • Hadassah Medical Center, Jerusalem, Israel

  • Hadassah Medical Center,Jerusalem,Израиль

  • School of Clinical Sciences at Monash Health, Monash University

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • City of Hope,Duarte,États-unis

  • Dana-Farber Cancer Institute Boston,Boston,Stati Uniti

  • University Hospital of Cologne,Cologne,Германия

  • Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel

  • Jewish General Hospital, Montreal, QC, Canada

  • University Hospital of Cologne,Cologne,Allemagne

  • University of Leipzig Medical Center,Leipzig,Germania

  • Co., Inc.,Kenilworth,Vereinigte Staaten

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • City of Hope,Duarte, CA,Estados Unidos

  • Rabin Medical Center, Petah Tikva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Co., Inc.,Kenilworth,Stati Uniti

  • CancerCare Manitoba,Winnipeg,Канада

  • Cancer Care Manitoba, Winnipeg, MB, Canada

  • City of Hope,Duarte,Vereinigte Staaten

  • City of Hope,Duarte,Stati Uniti

  • University Hospital of Cologne,Cologne,Allemagne

  • Jewish General Hospital, Montreal, QC, Canada

  • Monash University School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia

  • University of Leipzig Medical Center,Leipzig,Germania

  • Merck &amp

  • Univ. Hospital of Cologne, Cologne, Germany

  • Monash University School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia

  • Co., Inc, Kenilworth, NJ

  • University of Leipzig Medical School, Leipzig, Germany

  • Princess Margaret Cancer Centre,Toronto,Канада

  • Jewish General Hospital,Montreal,Канада

  • UCLA Medical Center Los Angeles CA United States

  • Princess Alexandra Hospital, Brisbane, Australia

  • City of Hope,Duarte,Vereinigte Staaten

  • UCLA Medical Center,Los Angeles,Estados Unidos

  • Sheba Medical Center, Ramat Gan, and Sackler Faculty of Medicine, Tel Aviv University,Tel Avi

  • Concord Hospital, University of Sydney, Concord, Australia

  • University of Leipzig Medical Center,Leipzig,Germania

  • Princess Alexandra Hospital

  • Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel

  • Dana-Farber Cancer Institute Boston,Boston,Stati Uniti

  • Rabin Medical Center, Petah Tikva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

  • Dana-Faber Cancer Institute,Boston,Verenigde Staten

  • Hadassah Medical Center, Jerusalem, Israel

  • Dana-Faber Cancer Institute,Boston,Verenigde Staten

  • Co., Inc.,Kenilworth,Vereinigte Staaten

  • University of Leip

  • City of Hope, Duarte, CA

  • Co., Inc.,Kenilworth, NJ,États-unis

  • Universit

  • University Hospital of Cologne,Cologne,Allemagne

  • University Hospital of Cologne,Cologne,Allemagne

  • Rabin Medical Center, Petah Tikva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

  • Tel Aviv Sourasky Med

  • University Hospital of Cologne,Cologne,Allemagne

  • Jewish General Hospital, Montreal, QC, Canada

  • University of Leipzig Medical Center,Leipzig,Germania

  • Concord Hospital, University of Sydney, Concord, Australia

  • Univ. Hospital of Cologne, Cologne, Germany

Locations

  • United States

  • Australia

  • Israel

  • Germany

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hodgkin's Lymphoma

Biomarkers

  • Programmed cell death protein 1

Drug/Treatment

  • Pembrolizumab

Outcome

  • N/A

Study Design

  • Open Label

  • Cohort

Phase

  • I/II

Study Id's

  • NCT03598608

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved